Simplex Trading’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.81M Buy
19,600
+2,700
+16% +$271K ﹤0.01% 1908
2025
Q4
$1.73M Sell
16,900
-34,100
-67% -$3.05M ﹤0.01% 2103
2025
Q3
$3.19M Sell
51,000
-11,200
-18% -$609K ﹤0.01% 1873
2025
Q2
$3.24M Sell
62,200
-17,700
-22% -$791K ﹤0.01% 1702
2025
Q1
$3.4M Buy
79,900
+39,400
+97% +$1.7M ﹤0.01% 1563
2024
Q4
$1.24M Sell
40,500
-12,300
-23% -$346K ﹤0.01% 2639
2024
Q3
$1.21M Sell
52,800
-45,800
-46% -$1.3M ﹤0.01% 2747
2024
Q2
$2.85M Sell
98,600
-123,100
-56% -$2.87M ﹤0.01% 1886
2024
Q1
$4.57M Buy
221,700
+181,100
+446% +$3.88M ﹤0.01% 1670
2023
Q4
$1.1M Buy
40,600
+10,900
+37% +$286K ﹤0.01% 2923
2023
Q3
$880K Buy
29,700
+7,500
+34% +$264K ﹤0.01% 2801
2023
Q2
$794K Sell
22,200
-15,100
-40% -$434K ﹤0.01% 2820
2023
Q1
$874K Sell
37,300
-40,300
-52% -$1.15M ﹤0.01% 2712
2022
Q4
$2.11M Sell
77,600
-19,200
-20% -$879K ﹤0.01% 1824
2022
Q3
$5.21M Buy
96,800
+47,800
+98% +$2.45M 0.01% 1174
2022
Q2
$1.98M Buy
49,000
+43,100
+731% +$2.14M ﹤0.01% 1880
2022
Q1
$390K Sell
5,900
-1,400
-19% -$95.8K ﹤0.01% 4182
2021
Q4
$730K Buy
7,300
+4,800
+192% +$496K ﹤0.01% 3306
2021
Q3
$317K Hold
2,500
﹤0.01% 4819
2021
Q2
$310K Buy
2,500
+2,466
+7,253% +$332K ﹤0.01% 4926
2021
Q1
$519K Sell
34
-141
-81% -$21.3K ﹤0.01% 3319
2020
Q4
$2.25M Sell
175
-349
-67% -$40.2K ﹤0.01% 1655
2020
Q3
$5.86M Buy
524
+307
+141% +$28.1K 0.01% 772
2020
Q2
$1.76M Sell
217
-113
-34% -$9.11K ﹤0.01% 1613
2020
Q1
$2.3M Sell
330
-194
-37% -$14.9K ﹤0.01% 1182
2019
Q4
$4.09M Buy
524
+209
+66% +$15.1K 0.01% 930
2019
Q3
$2.01M Sell
315
-64
-17% -$5.64K 0.01% 1334
2019
Q2
$3.27M Buy
379
+219
+137% +$16.7K 0.01% 955
2019
Q1
$1.23M Buy
+160
New +$8.87K ﹤0.01% 1817

Other funds holding GH

Simplex Trading's GH Position: Q1 2026 in Review

Simplex Trading sold out of Guardant Health (GH) in Q1 2026, closing a stake of 18,994 shares — an estimated $1.91M sold.

Simplex Trading first reported a position in GH in Q1 2019 and held it in 15 quarters. The position peaked at $4M in Q3 2022. 481 funds tracked by Wall St. Rank hold GH as of Q1 2026.

  • Simplex Trading reported no remaining Guardant Health position as of Q1 2026 after selling out during the quarter.
  • Simplex Trading sold 18,994 Guardant Health shares in Q1 2026, an estimated $1.91M.
  • Simplex Trading first reported a position in Guardant Health in Q1 2019 and held it in 15 quarters.
  • Simplex Trading's Guardant Health position peaked at $4M in Q3 2022.
  • 481 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.